Inventor · disambiguated record
Jeffrey Edwards
Also filed as: EDWARDS JEFFREY · EDWARDS JEFFREY H
5 granted patents·7 pending applications·31 citations·filing 1992–2021
78Inventor score
Top patents by PatentIndex Score
12 records- 0193US10052337B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Aug 21, 2018·21 cites·19 claims
- 0287US10758549B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2020·Granted Sep 1, 2020·2 cites·33 claims
- 0383US10646499B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted May 12, 2020·1 cites·20 claims
- 0475US2022133745A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0574US10751349B2Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·0 cites·22 claims
- 0667US2020046736A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0767US2020046735A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0867US2020054650A1Compositions of obeticholic acid and methods of useINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0960US2022184099A1Methods of using obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1058US5214155AMethod for 1,2-substituted imidazoline compositionsTEXACO CHEMICAL·Filed 1992·Granted May 25, 1993·7 cites·4 claims
- 1150US2020316092A1Methods of diagnosis and treatment of liver diseases using obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1249US2020147108A1Methods of using obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Edwards files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →